Delisting riskPopularity #3,854
SNYR · NASDAQ · Medical - Distribution

Synergy CHC (SNYR)

Consumer-health owner of FOCUSfactor supplements and Flat Tummy wellness products.

$0.0905
vs last close0.00 (0.00%)
Loading prices…

Synergy CHC Corp.SNYR
Health Care

Develops and markets FOCUSfactor brain-health supplements and beverages and Flat Tummy weight-management products, earning most revenue through major retailers and online channels. An asset-light model relies on contract manufacturers while sales remain concentrated in North American nutraceuticals.

Builds consumer-health brands around FOCUSfactor brain-health supplements and focus-plus-energy beverages, alongside Flat Tummy nutritional weight-management products. Most sales flow through major retailers, including Costco, Amazon, Walmart, Walgreens, BJ's, and The Vitamin Shoppe, complemented by direct-to-consumer sites. Revenue is concentrated in North America, with FOCUSfactor also available in Canada and Mexico.

Operates an asset-light model centered on brand management, marketing, product development, and distribution, while third parties manufacture products and support research. FOCUSfactor and Flat Tummy are the current priorities; the company also owns several non-core brands. Customer placements, outsourced suppliers, shifting consumer preferences, and dietary-supplement product, labeling, advertising, and distribution rules shape the business.

Company facts

CEOJack Ross
ListedOct 23, 2024
ExchangeNASDAQ
HeadquartersNorth Windham, ME
CountryUnited States
Employees28
CIK0001562733
ISINUS87165D2080

Market cap$941.8K
EPS (ttm)−$1.60
P/E (ttm)−0.0566
ROE
P/B
P/S0.0340
Dividend yieldDiv yield
Beta−0.46vs XLV 0.02

Price target$7.50+8,233.3%Average of 2 analysts
ConsensusBuy2 of 2 analysts
Ratings

Target rangeAs of Sep 17, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Feb 2, 2026AscendiantTarget
Target:
Target: $5

Next report
Nov 12, 26
in 51 days
EPS estimate
$0.01
Revenue estimate
$9.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported$0.01$0.10$0.17$0.01−$0.31−$0.23−$0.01Pending
Estimate$0.10$0.07$0.08$0.01$0.01$0.03−$0.01$0.01
Surprise−90.0%+42.9%+112.5%0.0%−3,200.0%−866.7%0.0%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported$10.3M$8.2M$8.1M$8.0M$6.1M$5.5M$8.0MPending
Estimate$9.0M$10.8M$10.8M$10.9M$10.8M$8.3M$8.0M$9.0M
Surprise+14.1%−24.3%−25.0%−26.5%−44.0%−34.1%0.0%
Estimate$0.01
ReportedDue Nov 12, 2026
Estimate$9.0M
ReportedDue Nov 12, 2026
View details

Current ratio92.60%

ProfitabilityRevenueNet incomeNet margin

Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue$8.0M$7.1M$10.3M$8.2M$8.1M$8.0M$6.1M$5.5M
Net income$655.2K$783.6K$105.7K$876.3K$1.5M$125.3K−$14.8M−$2.6M
Net margin8.2%11.0%1.0%10.7%18.1%1.6%0.0%0.0%

GrowthOperating income

Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Operating income$1.6M$1.1M$1.4M$1.9M$1.6M$1.3M−$6.6M−$567.1K
YoY growth−48.6%−51.1%−69.3%+7.7%+2.5%+21.8%Turned lossTurned loss

Balance sheet, Mar 31, 2026Cash & short-term investments $292.1K · Total debt $27.7M · Total assets $6.5M · Shareholders' equity −$25.4M

Revenue
$5.5M
Operating income
−$567.1K
Net income
−$2.6M
View details

No dividends on record.

Institutions5.66%589.4K shares
14 holders · as of Jun 30, 2026
Insiders11.07%1.15M shares
4 holders · as of Apr 24, 2026
Strategic holders18.37%1.91M shares
1 holder · as of Jun 13, 2025
Other64.90%6.75M shares
remainder

10.41M company shares as of Sep 19, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (14.90M in the company's Sep 22, 2026 report, 10.41M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Knight Therapeutics Inc1Strategic10 percent owner
18.37%1.91Mfiled Jun 13, 2025
Jack RossInsiderdirector, 10 percent owner, officer: CEO and Chairman
6.83%710,507filed Jul 31, 2025
Nitin KaushalInsiderdirector
2.94%306,433filed Apr 24, 2026
Jane Street Group, LLCInstitution
1.75%181,648as of Jun 30, 2026
Act Advisors, LLC.Institution
1.46%151,840as of Jun 30, 2026
  1. Knight Therapeutics Inc's transaction reports restate only vehicles that traded; the 2025 ownership statement (1.91M) is used instead.

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

  • Herbalife

    Formula 1 shakes and Herbal Tea target Flat Tummy's weight-management users.

  • Simply Good Foods

    Atkins nutrition contests Flat Tummy's GLP-1 and weight-management offer.

  • BellRing Brands

    Premier Protein shakes contest Flat Tummy's convenient protein nutrition.

  • Monster Beverage

    Reign and Bang contest focus-plus-energy beverage occasions and shelf space.

  • Celsius

    Functional energy drinks contest focus-plus-energy RTD occasions.

Compare

CompanyPriceChange
Synergy CHC$0.09050.00%$941.8K1.80.0−1.2%
Herbalife$12.13+1.76%$1.24B7.74.50.2+5.4%
Simply Good Foods$10.12+1.61%$880.9M6.10.6−6.3%
BellRing Brands$9.02+0.78%$1.04B6.37.50.4+4.2%
Monster Beverage$44.60+1.35%$86.06B40.636.49.3+20.2%
Celsius$29.59+5.60%$7.16B133.419.72.4+10.6%
Median24.17.50.6+5.4%